$KLIC
Kulicke and Soffa Industries Inc

2022 Q3 Form 10-Q Financial Statement

#000005697822000080 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $372.1M $384.3M $460.9M
YoY Change -12.3% 12.97% 72.06%
Cost Of Revenue $181.5M $182.6M $237.7M
YoY Change -20.63% -4.75% 62.36%
Gross Profit $190.7M $201.7M $223.2M
YoY Change -2.56% 35.84% 83.76%
Gross Profit Margin 51.24% 52.49% 48.44%
Selling, General & Admin $34.56M $35.09M $38.96M
YoY Change -11.61% 15.01% 8.52%
% of Gross Profit 18.13% 17.4% 17.45%
Research & Development $34.05M $37.28M $33.17M
YoY Change -5.79% 6.92% 5.15%
% of Gross Profit 17.85% 18.48% 14.86%
Depreciation & Amortization $4.101M $4.073M $5.339M
YoY Change 18.35% 25.52% 3.73%
% of Gross Profit 2.15% 2.02% 2.39%
Operating Expenses $68.61M $72.37M $72.13M
YoY Change -8.81% 10.7% 6.95%
Operating Profit $122.1M $129.3M $151.1M
YoY Change 1.35% 55.62% 179.62%
Interest Expense $36.00K $97.00K $40.00K
YoY Change -12.2% 31.08% 25.0%
% of Operating Profit 0.03% 0.07% 0.03%
Other Income/Expense, Net
YoY Change
Pretax Income $124.2M $129.7M $151.5M
YoY Change 2.66% 55.11% 177.24%
Income Tax $5.165M $13.71M $17.94M
% Of Pretax Income 4.16% 10.57% 11.84%
Net Earnings $119.0M $116.0M $133.6M
YoY Change 4.63% 62.65% 176.26%
Net Earnings / Revenue 31.99% 30.19% 28.99%
Basic Earnings Per Share $2.02 $1.89 $2.14
Diluted Earnings Per Share $1.99 $1.86 $2.11
COMMON SHARES
Basic Shares Outstanding 58.99M shares 61.48M shares 62.39M shares
Diluted Shares Outstanding 59.96M shares 62.44M shares 63.32M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $745.8M $690.5M $808.5M
YoY Change 17.45% 22.36% 40.19%
Cash & Equivalents $445.8M $460.5M $441.5M
Short-Term Investments $420.0M $300.0M $407.0M
Other Short-Term Assets $75.01M $51.43M $25.77M
YoY Change 242.16% 118.86% 21.53%
Inventory $215.3M $211.9M $197.2M
Prepaid Expenses
Receivables $350.0M $368.1M $431.6M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.386B $1.322B $1.463B
YoY Change 17.51% 27.63% 54.07%
LONG-TERM ASSETS
Property, Plant & Equipment $66.51M $67.04M $67.11M
YoY Change 0.42% 8.2% 10.13%
Goodwill $69.79M $71.47M $72.35M
YoY Change -5.29% -2.83% 26.18%
Intangibles $35.29M $38.44M $40.70M
YoY Change -21.63% -16.52% 8.32%
Long-Term Investments $5.397M $6.417M $6.412M
YoY Change 428.17%
Other Assets $2.911M $2.428M $2.436M
YoY Change 23.82% 5.93% 6.52%
Total Long-Term Assets $242.2M $237.1M $241.5M
YoY Change 5.16% 7.19% 22.47%
TOTAL ASSETS
Total Short-Term Assets $1.386B $1.322B $1.463B
Total Long-Term Assets $242.2M $237.1M $241.5M
Total Assets $1.628B $1.559B $1.705B
YoY Change 15.49% 24.03% 48.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $98.57M $100.2M $148.8M
YoY Change -31.67% -19.07% 66.48%
Accrued Expenses $59.27M $49.99M $47.37M
YoY Change -5.94% 6.14% 18.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $274.0M $274.9M $343.8M
YoY Change -11.1% 5.9% 71.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $14.66M $15.11M $14.60M
YoY Change 10.86% 14.74% 8.83%
Total Long-Term Liabilities $14.66M $15.11M $14.60M
YoY Change 10.86% 14.74% 8.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $274.0M $274.9M $343.8M
Total Long-Term Liabilities $14.66M $15.11M $14.60M
Total Liabilities $421.5M $421.8M $497.4M
YoY Change -3.43% 8.11% 46.65%
SHAREHOLDERS EQUITY
Retained Earnings $1.287B $1.177B $1.072B
YoY Change 56.22% 63.89% 63.4%
Common Stock $557.2M $522.9M $548.4M
YoY Change 2.03% -3.55% 1.85%
Preferred Stock
YoY Change
Treasury Stock (at cost) $615.7M $554.7M $408.8M
YoY Change 55.21% 41.26% 4.32%
Treasury Stock Shares 26.88M shares 25.90M shares 22.98M shares
Shareholders Equity $1.207B $1.137B $1.207B
YoY Change
Total Liabilities & Shareholders Equity $1.628B $1.559B $1.705B
YoY Change 15.49% 24.03% 48.64%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $119.0M $116.0M $133.6M
YoY Change 4.63% 62.65% 176.26%
Depreciation, Depletion And Amortization $4.101M $4.073M $5.339M
YoY Change 18.35% 25.52% 3.73%
Cash From Operating Activities $104.6M $73.13M $95.87M
YoY Change 15.02% 169.87% 63.51%
INVESTING ACTIVITIES
Capital Expenditures -$4.722M -$2.947M $2.711M
YoY Change -39.82% -26.33% -44.64%
Acquisitions
YoY Change
Other Investing Activities -$70.40M $137.1M $10.00M
YoY Change -217.2% 2264.12% 96.08%
Cash From Investing Activities -$75.12M $134.2M $7.289M
YoY Change -243.85% 7354.0% 3154.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $15.29M
YoY Change 783.07%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -39.84M -187.0M -$24.08M
YoY Change 209.28% 1788.76% 161.51%
NET CHANGE
Cash From Operating Activities 104.6M 73.13M $95.87M
Cash From Investing Activities -75.12M 134.2M $7.289M
Cash From Financing Activities -39.84M -187.0M -$24.08M
Net Change In Cash -10.34M 20.32M $78.70M
YoY Change -107.94% 6.95% 52.69%
FREE CASH FLOW
Cash From Operating Activities $104.6M $73.13M $95.87M
Capital Expenditures -$4.722M -$2.947M $2.711M
Free Cash Flow $109.3M $76.08M $93.16M
YoY Change 10.66% 144.64% 73.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2022-07-02
dei Entity Central Index Key
EntityCentralIndexKey
0000056978
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-01
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-07-02
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-121
dei Entity Registrant Name
EntityRegistrantName
KULICKE AND SOFFA INDUSTRIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-1498399
dei Entity Address Address Line1
EntityAddressAddressLine1
23A Serangoon North Avenue 5
dei Entity Address Address Line2
EntityAddressAddressLine2
#01-01,
dei Entity Address City Or Town
EntityAddressCityOrTown
Singapore
dei Entity Address Country
EntityAddressCountry
SG
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
554369
dei City Area Code
CityAreaCode
215
dei Local Phone Number
LocalPhoneNumber
784-6000
dei Security12b Title
Security12bTitle
Common Stock, Without Par Value
dei Trading Symbol
TradingSymbol
KLIC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58067945 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
445781000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
362788000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
300000000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
377000000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
687000 usd
CY2022Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
350045000 usd
CY2021Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
421193000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
215281000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
167323000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
75011000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23586000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1386118000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1351890000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66510000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
67982000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41160000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41592000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
69787000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
72949000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
35291000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
42752000 usd
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
21103000 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
15715000 usd
CY2022Q3 us-gaap Equity Securities Fv Ni And Without Readily Determinable Fair Value
EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
5397000 usd
CY2021Q4 us-gaap Equity Securities Fv Ni And Without Readily Determinable Fair Value
EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
6388000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2911000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2363000 usd
CY2022Q3 us-gaap Assets
Assets
1628277000 usd
CY2021Q4 us-gaap Assets
Assets
1601631000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
98572000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
154636000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5973000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4903000 usd
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
31060000 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
30766000 usd
CY2022Q3 klic Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
138434000 usd
CY2021Q4 klic Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
161570000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
274039000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
351875000 usd
us-gaap Basis Of Accounting
BasisOfAccounting
1. BASIS OF PRESENTATION<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (“we,” “us,” “our,” or the “Company”) with appropriate elimination of intercompany balances and transactions. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim consolidated condensed financial statements are unaudited and, in management's opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended October 2, 2021, filed with the Securities and Exchange Commission, which includes Consolidated Balance Sheets as of October 2, 2021 and October 3, 2020, and the related Consolidated Statements of Operations, Statements of Comprehensive Income, Changes in Shareholders' Equity and Cash Flows for each of the years in the three-year period ended October 2, 2021. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company's first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2022 quarters end on January 1, 2022, April 2, 2022, July 2, 2022 and October 1, 2022. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2021 quarters ended on January 2, 2021, April 3, 2021, July 3, 2021 and October 2, 2021. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designs, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company's operating results depend upon the capital and operating expenditures of semiconductor device manufacturers, integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), and other electronics manufacturers including automotive electronics suppliers worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry's demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, including those sold by the Company. These downturns and slowdowns have in the past adversely affected the Company's operating results. The Company believes such volatility will continue to characterize the industry and the Company's operations in the future.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company's assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the coronavirus (“COVID-19”) pandemic and macroeconomic headwinds, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of July 2, 2022. While there was no material impact to our consolidated condensed financial statements as of and for the quarter ended July 2, 2022, these estimates may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 and macroeconomic headwinds that could materially impact our consolidated condensed financial statements in future reporting periods. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for the accounting policies for contract assets and accelerated share repurchases described below, there have been no material changes to our significant accounting policies summarized in Note 1 "Basis of Presentation" to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended October 2, 2021. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A contract asset is the Company’s right to consideration in exchange for goods or services that the Company has transferred to a customer. ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, distinguishes between a contract asset and a receivable based on whether receipt of the consideration is conditional on something other than the passage of time. When the Company transfers control of goods or services to a customer before the customer pays consideration, the Company records either a contract asset or a receivable depending on the nature of the Company’s right to consideration for its performance. The point at which a contract asset becomes an account receivable may be earlier than the point at which an invoice is issued. The Company assesses a contract asset for impairment in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accelerated Share Repurchase </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may enter into accelerated share repurchase (“ASR”) agreements with third-party financial institutions to repurchase shares of the Company’s common stock. Under an ASR agreement, in exchange for an up-front payment, the counterparty makes an initial delivery of shares of the Company's common stock during the purchase period of the relevant ASR. This initial delivery of shares represents the minimum number of shares that the Company may receive under an ASR agreement. Upon settlement of an ASR agreement, the counterparty may deliver additional shares, with the final number of shares delivered determined based on the volume-weighted average price of the Company’s common stock over the term of such ASR agreement, less an agreed-upon discount. The transactions are accounted for as equity transactions and are included in Treasury Stock when the shares are received, at which time there is an immediate reduction in the weighted-average common shares calculation for basic and diluted earnings per share. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). The amendments in this ASU, among other changes, simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740, clarify and amend the existing guidance. We adopted this ASU in the first quarter of fiscal 2022. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contracts in Entity's Own Equity</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging - Contracts in Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 815). The amendments in this ASU, among other changes, remove current guidance that allows an entity to rebut the presumption that potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares if the entity has a history or policy of cash settlement. These amendments affect any instrument that may be settled in cash or shares and, therefore, affects the diluted earnings per share calculation for both convertible instruments and contracts in an entity's own equity. We elected to early adopt this ASU in the second quarter of fiscal 2022. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span>. The amendments in this ASU affect a wide variety of topics in the Codification and improve the consistency of the Codification by including all disclosure guidance in the appropriate disclosure sections (Section 50). We adopted this ASU in the first quarter of fiscal 2022. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
34541000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
32828000 usd
CY2022Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
62468000 usd
CY2021Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
69422000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
35836000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
38084000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14660000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14185000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
421544000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
506394000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1286505000 usd
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85364000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85364000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58480000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61931000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
557236000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
550117000 usd
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
26884000 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
23433000 shares
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
615689000 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
400412000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
948554000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21319000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3022000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1206733000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1095237000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1628277000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1601631000 usd
CY2022Q3 us-gaap Revenues
Revenues
372137000 usd
CY2021Q3 us-gaap Revenues
Revenues
424318000 usd
us-gaap Revenues
Revenues
1217307000 usd
us-gaap Revenues
Revenues
1032338000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
181452000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
228623000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
601674000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
566667000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
190685000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
195695000 usd
us-gaap Gross Profit
GrossProfit
615633000 usd
us-gaap Gross Profit
GrossProfit
465671000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34562000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39103000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
108609000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
105511000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34046000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36137000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
104496000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
102549000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
68608000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
75240000 usd
us-gaap Operating Expenses
OperatingExpenses
213105000 usd
us-gaap Operating Expenses
OperatingExpenses
208060000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
122077000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
120455000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
402528000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
257611000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2158000 usd
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
564000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
3099000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1801000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
36000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
41000 usd
us-gaap Interest Expense
InterestExpense
173000 usd
us-gaap Interest Expense
InterestExpense
146000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
124199000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
120978000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
405454000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
259266000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5165000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7212000 usd
CY2022Q1 klic Stock Repurchase Program Authorized Amount Additional Amount
StockRepurchaseProgramAuthorizedAmountAdditionalAmount
400000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36813000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25722000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-94000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
119034000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
113766000 usd
us-gaap Net Income Loss
NetIncomeLoss
368641000 usd
us-gaap Net Income Loss
NetIncomeLoss
233450000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.02
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.83
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.76
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.99
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1868000 usd
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.79
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.68
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58985000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62023000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60951000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62023000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59955000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63485000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61940000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63364000 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
119034000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
113766000 usd
us-gaap Net Income Loss
NetIncomeLoss
368641000 usd
us-gaap Net Income Loss
NetIncomeLoss
233450000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-12009000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-18025000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3854000 usd
CY2022Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-122000 usd
CY2021Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
79000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-103000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-1000 usd
CY2022Q3 klic Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent
ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent
-11887000 usd
CY2021Q3 klic Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent
ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent
1789000 usd
klic Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent
ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent
-17922000 usd
klic Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent
ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent
3855000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12950000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1339000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-18297000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2861000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
106084000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
115105000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
350344000 usd
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10110000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
236311000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1095237000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
238000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
15380000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5074000 usd
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10610000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
133606000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-989000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
132617000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1207176000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
237000 usd
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
176153000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4459000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
116001000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4358000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
111643000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1137252000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
237000 usd
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
31098000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4228000 usd
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
9970000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
119034000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12950000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
106084000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1206733000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
757994000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
173000 usd
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1206000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3216000 usd
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8687000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
48363000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7763000 usd
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
56126000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
807616000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
185000 usd
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1110000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3778000 usd
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8688000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
71320000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6241000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
65079000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
866860000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
224000 usd
CY2021Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4087000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3918000 usd
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8678000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
113766000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1339000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
115105000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
973342000 usd
us-gaap Net Income Loss
NetIncomeLoss
368641000 usd
us-gaap Net Income Loss
NetIncomeLoss
233450000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15773000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14552000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
1346000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
14473000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
11504000 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
1046000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-245000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-95000 usd
klic Increase Decrease Due To Inventory Valuation
IncreaseDecreaseDueToInventoryValuation
1110000 usd
klic Increase Decrease Due To Inventory Valuation
IncreaseDecreaseDueToInventoryValuation
-834000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3675000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10587000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
129000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-25000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
3806000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-719000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-94000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-71825000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
170403000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
49230000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
40771000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
50725000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2856000 usd
klic Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
-84017000 usd
klic Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
144717000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-6663000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2670000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1053000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-857000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
273625000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
176656000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
26338000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10380000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16747000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
119000 usd
CY2017Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
191000 usd
us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
397000 usd
us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
0 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
2115000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
389000000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
229000000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
466000000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
324000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
66342000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
54221000 usd
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
54500000 usd
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
22750000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
54500000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
22750000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
373000 usd
CY2018Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
200000000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
253000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
221139000 usd
us-gaap Interest Paid Net
InterestPaidNet
146000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6953000 usd
us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
29393000 usd
us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
24776000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-250905000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-31982000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-6069000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
977000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
82993000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
199872000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
362788000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188127000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
445781000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
387999000 usd
us-gaap Interest Paid Net
InterestPaidNet
173000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
50059000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
39405000 usd
us-gaap Fiscal Period
FiscalPeriod
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span>Each of the Company's first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2022 quarters end on January 1, 2022, April 2, 2022, July 2, 2022 and October 1, 2022. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2021 quarters ended on January 2, 2021, April 3, 2021, July 3, 2021 and October 2, 2021.
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company's assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.</span></div>Due to the coronavirus (“COVID-19”) pandemic and macroeconomic headwinds, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of July 2, 2022. While there was no material impact to our consolidated condensed financial statements as of and for the quarter ended July 2, 2022, these estimates may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 and macroeconomic headwinds that could materially impact our consolidated condensed financial statements in future reporting periods.
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
40363000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
40006000 usd
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
800000000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
300000000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
377000000 usd
CY2022Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
126593000 usd
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
94493000 usd
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
69426000 usd
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
55866000 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
236382000 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
190365000 usd
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
21101000 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
23042000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
215281000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
167323000 usd
CY2022Q3 us-gaap Land
Land
2182000 usd
CY2021Q4 us-gaap Land
Land
2182000 usd
CY2022Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
23116000 usd
CY2021Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
23314000 usd
CY2022Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
32120000 usd
CY2021Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
30054000 usd
CY2022Q3 klic Equipment And Software Gross
EquipmentAndSoftwareGross
40836000 usd
CY2021Q4 klic Equipment And Software Gross
EquipmentAndSoftwareGross
40945000 usd
CY2022Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
90465000 usd
CY2021Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
87994000 usd
CY2022Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
10728000 usd
CY2021Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
9562000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
199447000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
194051000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
132937000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
126069000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66510000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
67982000 usd
CY2022Q3 srt Payables To Customers
PayablesToCustomers
67063000 usd
CY2021Q4 srt Payables To Customers
PayablesToCustomers
72478000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
47833000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
66531000 usd
CY2022Q3 klic Accrued Liabilities For Commission And Professional Fees Current
AccruedLiabilitiesForCommissionAndProfessionalFeesCurrent
9970000 usd
CY2021Q4 klic Accrued Liabilities For Commission And Professional Fees Current
AccruedLiabilitiesForCommissionAndProfessionalFeesCurrent
8673000 usd
CY2022Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
5459000 usd
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
6190000 usd
CY2022Q3 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
0 usd
CY2021Q4 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
31000 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8109000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7667000 usd
CY2022Q3 klic Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
138434000 usd
CY2021Q4 klic Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
161570000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
72949000 usd
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-3162000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
69787000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
35291000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
42752000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1416000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5665000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5665000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5665000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5665000 usd
CY2022Q3 klic Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
11215000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
35291000 usd
CY2022Q3 us-gaap Cash
Cash
164458000 usd
CY2022Q3 klic Cash Unrealized Gains
CashUnrealizedGains
0 usd
CY2022Q3 klic Cash Unrealized Losses
CashUnrealizedLosses
0 usd
CY2022Q3 klic Cash Estimated Fair Value
CashEstimatedFairValue
164458000 usd
CY2022Q3 klic Cashand Cash Equivalents Amortized Cost
CashandCashEquivalentsAmortizedCost
445805000 usd
CY2022Q3 klic Cashand Cash Equivalents Gross Unrealized Gain
CashandCashEquivalentsGrossUnrealizedGain
0 usd
CY2022Q3 klic Cashand Cash Equivalents Gross Unrealized Loss
CashandCashEquivalentsGrossUnrealizedLoss
24000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
445781000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
300000000 usd
CY2022Q3 klic Availableforsale Securities Shortterm Investments Gross Unrealized Gain
AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedGain
0 usd
CY2022Q3 klic Availableforsale Securities Shortterm Investments Gross Unrealized Loss
AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedLoss
0 usd
CY2022Q3 klic Availableforsale Securities Shortterm Investments Fair Value Disclosure
AvailableforsaleSecuritiesShorttermInvestmentsFairValueDisclosure
300000000 usd
CY2022Q3 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestments
745805000 usd
CY2022Q3 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Gain
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedGain
0 usd
CY2022Q3 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Loss
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedLoss
24000 usd
CY2022Q3 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Fair Value Disclosure
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsFairValueDisclosure
745781000 usd
CY2021Q4 us-gaap Cash
Cash
269201000 usd
CY2021Q4 klic Cash Unrealized Gains
CashUnrealizedGains
0 usd
CY2021Q4 klic Cash Unrealized Losses
CashUnrealizedLosses
0 usd
CY2021Q4 klic Cash Estimated Fair Value
CashEstimatedFairValue
269201000 usd
CY2021Q4 klic Cashand Cash Equivalents Amortized Cost
CashandCashEquivalentsAmortizedCost
362806000 usd
CY2021Q4 klic Cashand Cash Equivalents Gross Unrealized Gain
CashandCashEquivalentsGrossUnrealizedGain
0 usd
CY2021Q4 klic Cashand Cash Equivalents Gross Unrealized Loss
CashandCashEquivalentsGrossUnrealizedLoss
18000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
362788000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
377000000 usd
CY2021Q4 klic Availableforsale Securities Shortterm Investments Gross Unrealized Gain
AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedGain
0 usd
CY2021Q4 klic Availableforsale Securities Shortterm Investments Gross Unrealized Loss
AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedLoss
0 usd
CY2021Q4 klic Availableforsale Securities Shortterm Investments Fair Value Disclosure
AvailableforsaleSecuritiesShorttermInvestmentsFairValueDisclosure
377000000 usd
CY2021Q4 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestments
739806000 usd
CY2021Q4 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Gain
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedGain
0 usd
CY2021Q4 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Loss
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedLoss
18000 usd
CY2021Q4 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Fair Value Disclosure
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsFairValueDisclosure
739788000 usd
CY2022Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
57756000 usd
CY2022Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
991000 usd
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
5397000 usd
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
6388000 usd
CY2022Q3 us-gaap Equity Securities Fv Ni And Without Readily Determinable Fair Value
EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
5397000 usd
CY2021Q4 us-gaap Equity Securities Fv Ni And Without Readily Determinable Fair Value
EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
6388000 usd
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
1300000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
1300000 usd
klic Period Of Warranty For Manufacturing Defects
PeriodOfWarrantyForManufacturingDefects
P1Y
CY2021Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
57682000 usd
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
616000 usd
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimate Of Time To Transfer1
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1
P12M
klic Leases Numberof Options To Extend
LeasesNumberofOptionsToExtend
0 extend_options
CY2022Q3 us-gaap Lease Cost
LeaseCost
2173000 usd
CY2021Q3 us-gaap Lease Cost
LeaseCost
1894000 usd
us-gaap Lease Cost
LeaseCost
6217000 usd
us-gaap Lease Cost
LeaseCost
5693000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
5715000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
5364000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12068000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y6M
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y7M6D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.057
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.058
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2095000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8133000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7680000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6935000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5006000 usd
CY2022Q3 klic Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
24028000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
53877000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
41809000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5973000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
35836000 usd
CY2022Q3 us-gaap Pension Contributions
PensionContributions
419000 usd
CY2021Q3 us-gaap Pension Contributions
PensionContributions
458000 usd
us-gaap Pension Contributions
PensionContributions
1423000 usd
us-gaap Pension Contributions
PensionContributions
1324000 usd
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
300000000 usd
CY2020Q3 klic Stock Repurchase Program Authorized Amount Additional Amount
StockRepurchaseProgramAuthorizedAmountAdditionalAmount
400000000 usd
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
800000000 usd
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.17
CY2022Q3 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
10100000 usd
us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
29400000 usd
klic Relative Total Shareholder Return Average Stock Price Calculation Period
RelativeTotalShareholderReturnAverageStockPriceCalculationPeriod
P90D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
5000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
4000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
546000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
708000 shares
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4465000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4140000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14473000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11504000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4465000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4140000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14473000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11504000 usd
CY2022Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
26721000 usd
CY2021Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2022Q3 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
18563000 usd
CY2021Q3 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7200000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
45284000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
45284000 usd
CY2021Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
45284000 usd
CY2021Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17300000 usd
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5788000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
15596000 usd
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2958000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-29612000 usd
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-23725000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-104796000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-43993000 usd
CY2022Q3 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
17996000 usd
CY2021Q3 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
26486000 usd
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
94884000 usd
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
49584000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5684000 usd
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8549000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5684000 usd
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8549000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
119034000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
119034000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
113766000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
113766000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58985000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58985000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62023000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62023000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
970000 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1462000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59955000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63485000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.02
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.83
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.83
CY2022Q3 klic Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
-0.03
CY2021Q3 klic Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
-0.04
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.99
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.79
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Net Income Loss
NetIncomeLoss
368641000 usd
us-gaap Net Income Loss
NetIncomeLoss
368641000 usd
us-gaap Net Income Loss
NetIncomeLoss
233450000 usd
us-gaap Net Income Loss
NetIncomeLoss
233450000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60951000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60951000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62023000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62023000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
989000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1341000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61940000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63364000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.76
klic Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
-0.10
klic Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.68
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000 shares
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5165000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7212000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36813000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25722000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.042
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.060
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.091
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.099
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4900000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2022Q3 us-gaap Revenues
Revenues
372137000 usd
CY2021Q3 us-gaap Revenues
Revenues
424318000 usd
us-gaap Revenues
Revenues
1217307000 usd
us-gaap Revenues
Revenues
1032338000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
122077000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
120455000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
402528000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
257611000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
15518000 usd
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
15574000 usd
CY2022Q3 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
4953000 usd
CY2021Q3 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
7956000 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
11213000 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
16763000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
4101000 usd
CY2021Q3 us-gaap Depreciation
Depreciation
3465000 usd
us-gaap Depreciation
Depreciation
12230000 usd
us-gaap Depreciation
Depreciation
9899000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1109000 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1340000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3543000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4653000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
16961000 usd
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
9576000 usd
CY2022Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2842000 usd
CY2021Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
4325000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
9001000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
15654000 usd
CY2022Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
4118000 usd
CY2021Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3004000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
11720000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
8335000 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
14242000 usd
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
16895000 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
14242000 usd
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
16895000 usd
CY2022Q3 klic Inventory Purchase Obligation Future Minimum Payments Due
InventoryPurchaseObligationFutureMinimumPaymentsDue
347900000 usd
CY2022Q3 klic Inventory Purchase Obligation Future Minimum Payments Due Current
InventoryPurchaseObligationFutureMinimumPaymentsDueCurrent
113400000 usd
CY2022Q3 klic Inventory Purchase Obligation Future Minimum Payments Due In Two Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInTwoYears
234500000 usd
CY2022Q3 klic Inventory Purchase Obligation Future Minimum Payments Due In Three Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInThreeYears
0 usd
CY2022Q3 klic Inventory Purchase Obligation Future Minimum Payments Due In Four Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInFourYears
0 usd
CY2022Q3 klic Inventory Purchase Obligation Future Minimum Payments Due In Five Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInFiveYears
0 usd
CY2022Q3 klic Inventory Purchase Obligation Future Minimum Payments Due Thereafter
InventoryPurchaseObligationFutureMinimumPaymentsDueThereafter
0 usd

Files In Submission

Name View Source Status
0000056978-22-000080-index-headers.html Edgar Link pending
0000056978-22-000080-index.html Edgar Link pending
0000056978-22-000080.txt Edgar Link pending
0000056978-22-000080-xbrl.zip Edgar Link pending
a10qq32022ex311.htm Edgar Link pending
a10qq32022ex312.htm Edgar Link pending
a10qq32022ex321.htm Edgar Link pending
a10qq32022ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
klic-20220702.htm Edgar Link pending
klic-20220702.xsd Edgar Link pending
klic-20220702_cal.xml Edgar Link unprocessable
klic-20220702_def.xml Edgar Link unprocessable
klic-20220702_htm.xml Edgar Link completed
klic-20220702_lab.xml Edgar Link unprocessable
klic-20220702_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending